Skip to content

Clinical trials

Phase 1/2 Lymphoma, Follicular trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 1/2 Country / region: Netherlands Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20162
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Celgene1
Edwards Lifesciences1
Genentech, Inc.1
Lakefront Biotherapeutics NV1
Nordic Nanovector1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular7
Lymphoma, Large B-Cell, Diffuse5
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Mantle-Cell3
Lymphoma, Non-Hodgkin3
Lymphoma, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Burkitt Lymphoma1
Gastroesophageal Reflux1
Hodgkin Disease1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.